Secondary Metabolites from Bacillus spp. probiotics as potential treatments for multidrug-resistant pathogens: A comprehensive review
Open Access
- 16 April 2025
- journal article
- review article
- Published by Elsevier in Current Research in Microbial Sciences
- Vol. 8, 100392
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Effects of branched-chain amino acids on surfactin structure and antibacterial activity in Bacillus velezensis YA215World Journal of Microbiology and Biotechnology, 2024
- Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic AbnormalityProbiotics and Antimicrobial Proteins, 2022
- Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature ReviewAdvances in Therapy, 2022
- Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutionsJournal of Biosciences, 2021
- Difficidin class of polyketide antibiotics from marine macroalga-associated Bacillus as promising antibacterial agentsApplied Microbiology and Biotechnology, 2021
- Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiotaApplied Microbiology and Biotechnology, 2020
- Streptomyces: implications and interactions in plant growth promotionApplied Microbiology and Biotechnology, 2018
- Plipastatin and surfactin coproduction by Bacillus subtilis pB2-L and their effects on microorganismsAntonie van Leeuwenhoek, 2017
- Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strainWorld Journal of Microbiology and Biotechnology, 2016
- Clinical Study of Bacillus coagulans Unique IS-2 (ATCC PTA-11748) in the Treatment of Patients with Bacterial VaginosisIndian Journal of Microbiology, 2011